Release week 2025-01-29
⭐ This week's notable releases
4 novel sequences, 11 confidently wrong. Highlight: Prolactin-releasing peptide PrRP31.
| PDB | Protein | Flags | Why it matters |
|---|---|---|---|
|
|
Prolactin-releasing peptide PrRP31 | novel · 100% confidently wrong | Genuinely unseen sequence (0% identity to anything AlphaFold trained on) — and AlphaFold got the fold wrong despite high confidence. |
|
|
Prolactin-releasing peptide PrRP31 | novel · 100% confidently wrong | Genuinely unseen sequence (0% identity to anything AlphaFold trained on) — and AlphaFold got the fold wrong despite high confidence. |
|
|
Muellerian-inhibiting factor | novel · 100% | Genuinely unseen sequence (0% identity to anything AlphaFold trained on). |
|
|
Muellerian-inhibiting factor | novel · 100% | Genuinely unseen sequence (0% identity to anything AlphaFold trained on). |
|
|
Alpha-synuclein | confidently wrong disease | A close pre-cutoff homolog existed (100% identity to 1XQ8_1) yet AlphaFold confidently missed the fold. Disease-linked. |
|
|
Alpha-synuclein | confidently wrong disease | A close pre-cutoff homolog existed (100% identity to 1XQ8_1) yet AlphaFold confidently missed the fold. Disease-linked. |
Zoomed into the red "confidently wrong" box above (pLDDT ≥ 70, TM < 0.5) — the structures AlphaFold got confidently wrong.
The worst offenders ranked, one row per protein (AlphaFold has one model per sequence, so repeat depositions are collapsed — “×N” marks how many structures of that protein exist; the worst is shown). Each row joins what AlphaFold claimed (blue, pLDDT/100) to what the experiment showed (red, TM-score) — the longer the bar, the bigger the miss. Hover a dot to preview its Cα-deviation ribbon; click to open the full entry.
How to read this
Every point is one experimental protein structure. The horizontal axis is AlphaFold's own confidence in its prediction (mean pLDDT, 0–100). The vertical axis is how well that blind prediction actually matches the experiment (TM-score, 0–1; above 0.5 means the same fold, above 0.9 near-identical). Marker size grows with the FRAUD score (confidence-weighted error).
Cutoff: the shaded red box is the "confidently wrong" zone — AlphaFold was confident (mean pLDDT above 70) yet the fold is wrong (TM-score below 0.5). A predictor that had truly solved folding would leave that box empty.
Take-home: 11 of 154 structures (7.1%) are confidently wrong; median TM-score is 0.968.
Read moreShow less — how each metric is calculated
TM-score: how similar the two 3D shapes are overall, 0–1 (a random pair scores ~0.17, an identical fold ~1). Length-normalised so large and small proteins compare fairly. TM = (1/L) Σᵢ 1/(1 + (dᵢ/d₀)²) — dᵢ is the gap between the i-th aligned Cα atoms after best-fit superposition, and d₀ = 1.24(L−15)^⅓ − 1.8 sets the distance scale for length L. Ref: Zhang & Skolnick, Proteins 2004 doi:10.1002/prot.20264; computed with TM-align, doi:10.1093/nar/gki524.
pLDDT: AlphaFold's own confidence in each residue, 0–100 (higher = surer). It is the model predicting its own accuracy before ever seeing the experiment. We plot the per-structure mean. pLDDT = (1/N) Σᵢ pLDDTᵢ, where pLDDTᵢ is the network's confidence output for residue i.
FRAUD score: the headline number — how wrong the prediction was, weighted by how confident AlphaFold was, so a big error it was sure about counts most. FRAUD = (1/N) Σᵢ (pLDDTᵢ/100) · min(Δᵢ,15)/15, where Δᵢ is residue i's Cα distance from the experiment (Å) after superposition, capped at 15 Å. Runs 0 (perfect) to 1.
Novelty: how little AlphaFold had to go on — 100 minus the highest sequence identity between this protein and any structure released before the 2018-04-30 training cutoff. High = genuinely unseen (100% = nothing similar was ever in the training set). novelty = 100 − maxₚ identity(s, p) over pre-cutoff PDB chains p, with identity = 100 × (matching aligned residues)/(alignment length), from an MMseqs2 search.
Homology: the point colour. High novelty (above 70%) flags the sequence as novel (amber) — AlphaFold had no close template; otherwise a pre-cutoff homolog existed (blue) it could have learned the fold from. novel ⇔ novelty > 70%.
What the metrics mean
TM-score (0–1): overall fold match — above 0.5 is the same fold, above 0.9 near-identical. Cα-RMSD (Å): average backbone distance after best-fit superposition — lower is better (under 2 Å is excellent). lDDT (0–1): local accuracy measured without superposition — above 0.8 is good. Each bar counts how many structures fall in that range.
Take-home: median TM-score 0.968 — most predictions match the experimental fold well, with a long tail that do not.
Read moreShow less — how each metric is calculated
TM-score: overall shape match, 0–1 (above 0.5 = same fold, above 0.9 near-identical), length-normalised. TM = (1/L) Σᵢ 1/(1 + (dᵢ/d₀)²) with dᵢ the aligned-Cα gap after superposition and d₀ = 1.24(L−15)^⅓ − 1.8. Ref: Zhang & Skolnick, Proteins 2004 doi:10.1002/prot.20264.
Cα-RMSD: the average straight-line distance between matching backbone Cα atoms once the two structures are best-fit superposed (Å; lower is better, under ~2 Å excellent). RMSD = √( (1/N) Σᵢ |Pᵢ − (R·Qᵢ + t)|² ), with Pᵢ/Qᵢ the experimental/model Cα coordinates and R,t the rotation and translation from Kabsch superposition.
lDDT: local accuracy with no superposition — the fraction of short-range inter-residue distances the model reproduces, so it is not fooled by a single wrongly-placed domain. lDDT = (1/N) Σᵢ ¼ Σ_t 1[ |d_exp − d_model| < t ] over thresholds t ∈ {0.5, 1, 2, 4} Å and all residue pairs within 15 Å.
Trend over time
The blue line is the mean TM-score of the structures by their deposit month; the red bars count how many were confidently wrong. Binning by deposit date (rather than by when we processed them) gives an even timeline, tracking whether AlphaFold's accuracy on newly-deposited structures is holding steady, improving, or slipping as the PDB keeps growing. Months with fewer than 5 structures are omitted so each point is a meaningful average. A dashed trend line is drawn only if the change over time is statistically significant.
Read moreShow less — how each metric is calculated
Mean TM-score: the month's average shape-match score. TM̄ = (1/M) Σ TM over the M structures deposited that month.
Trend line: a monotonic-trend test over the monthly means — Mann-Kendall (Kendall's τ) for significance, with a robust Theil-Sen slope for the line. Rank-based, so it tolerates the skewed TM distribution and noisy low-count months. Shown only when p < 0.05; otherwise a note reports that no significant trend was found.
Confidently wrong: the count that were both confident and wrong. count( mean pLDDT > 70 AND TM < 0.5 ).
Matched structures
| PDB | UniProt | Protein | Method | Å | Deposited | Novelty % | pLDDT | TM | lDDT | GDT_TS | RMSD | FRAUD | Flag |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9HGR_A | P37840 | Alpha-synuclein | EM | 2.70 | 2024-11-20 | 0.00 | 86.96 | 0.20 | 0.24 | 0.00 | 34.95 | 0.85 | wrong |
| 8Y2Q_A | P37840 | Alpha-synuclein | EM | 2.80 | 2024-01-27 | 0.00 | 85.21 | 0.27 | 0.29 | 0.91 | 20.62 | 0.79 | wrong |
| 8Y2P_A | P37840 | Alpha-synuclein | EM | 3.20 | 2024-01-27 | 0.00 | 85.21 | 0.27 | 0.29 | 0.91 | 20.70 | 0.79 | wrong |
| 9HGS_C | P37840 | Alpha-synuclein | EM | 3.00 | 2024-11-20 | 0.80 | 83.77 | 0.19 | 0.30 | 1.00 | 29.62 | 0.78 | wrong |
| 9BUR_B | P02818 | Osteocalcin | EM | 2.95 | 2024-05-17 | 8.20 | 82.51 | 0.28 | 0.68 | 4.17 | 15.07 | 0.69 | wrong |
| 8Y20_A | Q07820 | Maltose/maltodextrin-binding periplasmic p | X-ray | 2.23 | 2024-01-25 | 0.00 | 67.34 | 0.33 | 0.54 | 0.69 | 34.65 | 0.64 | ok |
| 8ZU8_A | Q92508 | Piezo-type mechanosensitive ion channel co | EM | 3.90 | 2024-06-08 | 16.40 | 84.19 | 0.68 | 0.85 | 6.78 | 19.04 | 0.64 | ok |
| 9BUX_B | P02818 | Osteocalcin | EM | 3.06 | 2024-05-17 | 8.20 | 81.28 | 0.28 | 0.67 | 6.43 | 14.68 | 0.62 | wrong |
| 8Y56_R | Q7Z3F1 | Lysosomal cholesterol signaling protein | EM | 2.83 | 2024-01-31 | 63.70 | 84.43 | 0.66 | 0.89 | 16.08 | 8.60 | 0.44 | ok |
| 8K50_C | P01116 | KRAS G12V peptide (VVVGAVGVGK) | X-ray | 2.80 | 2023-07-20 | — | 96.46 | 0.33 | 0.74 | 35.00 | 4.76 | 0.28 | wrong |
| 8ZB7_L | P09493 | Tropomyosin alpha-1 chain | EM | 3.19 | 2024-04-26 | — | 91.62 | 0.70 | — | — | — | 0.27 | ok |
| 8K4T_C | P01116 | KRAS G12C peptide (VVVGACGVGK) | X-ray | 2.30 | 2023-07-20 | — | 96.46 | 0.30 | 0.61 | 45.00 | 4.54 | 0.25 | wrong |
| 8Y1Z_B | Q16611 | Short BH3 peptide from Bcl-2 homologous an | X-ray | 1.91 | 2024-01-25 | — | 81.31 | 0.70 | — | — | — | 0.24 | ok |
| 8K4V_C | P01116 | KRAS G12R peptide (VVVGARGVGK) | X-ray | 3.10 | 2023-07-20 | — | 96.46 | 0.33 | 0.58 | 45.00 | 4.33 | 0.24 | wrong |
| 9K26_C | P63096 | Guanine nucleotide-binding protein G(i) su | EM | 3.00 | 2024-10-17 | — | 93.75 | 0.81 | — | — | — | 0.18 | ok |
| 8ZEB_A | Q07817 | Bcl-2-like protein 1 | X-ray | 1.95 | 2024-05-05 | — | 72.50 | 0.76 | — | — | — | 0.18 | ok |
| 9K27_F | P81277 | Prolactin-releasing peptide PrRP31 | EM | 2.68 | 2024-10-17 | 100.00 novel | 71.85 | 0.16 | 0.70 | 47.22 | 4.36 | 0.17 | wrong |
| 9K26_F | P81277 | Prolactin-releasing peptide PrRP31 | EM | 3.00 | 2024-10-17 | 100.00 novel | 71.85 | 0.16 | 0.70 | 47.22 | 4.36 | 0.17 | wrong |
| 9BAO_B | P03971 | Muellerian-inhibiting factor | EM | 3.20 | 2024-04-04 | — | 68.62 | 0.75 | — | — | — | 0.17 | ok |
| 9BAN_B | P03971 | Muellerian-inhibiting factor | EM | 3.39 | 2024-04-04 | — | 68.62 | 0.75 | — | — | — | 0.17 | ok |
| 9K27_E | P50148 | Guanine nucleotide-binding protein G(q) su | EM | 2.68 | 2024-10-17 | — | 93.00 | 0.83 | — | — | — | 0.16 | ok |
| 9FJX_A | Q16531 | DNA damage-binding protein 1 | X-ray | 2.00 | 2024-05-31 | — | 92.00 | 0.83 | — | — | — | 0.15 | ok |
| 9BAN_A | P03971 | Muellerian-inhibiting factor | EM | 3.39 | 2024-04-04 | 100.00 novel | 72.29 | 0.69 | 0.73 | 47.25 | 3.35 | 0.15 | ok |
| 9GXA_B | P62805 | Histone H4 | EM | 4.01 | 2024-09-29 | — | 89.81 | 0.84 | — | — | — | 0.14 | ok |
| 9GMK_K | Q9NRC8 | NAD-dependent protein deacetylase sirtuin- | EM | 3.50 | 2024-08-29 | — | 88.00 | 0.85 | — | — | — | 0.13 | ok |
| 8ZI9_M | P12883 | Myosin-7 | EM | 3.08 | 2024-05-13 | — | 74.25 | 0.83 | — | — | — | 0.13 | ok |
| 8ZB7_G | P12883 | Myosin-7 | EM | 3.19 | 2024-04-26 | — | 74.25 | 0.83 | — | — | — | 0.13 | ok |
| 8VVY_C | O75155 | Cullin-associated NEDD8-dissociated protei | EM | 3.49 | 2024-01-31 | — | 87.00 | 0.85 | — | — | — | 0.13 | ok |
| 9GXA_A | P49450 | Histone H3-like centromeric protein A | EM | 4.01 | 2024-09-29 | — | 81.50 | 0.85 | — | — | — | 0.12 | ok |
| 9BAO_A | P03971 | Muellerian-inhibiting factor | EM | 3.20 | 2024-04-04 | 100.00 novel | 65.93 | 0.64 | 0.75 | 56.70 | 3.08 | 0.11 | ok |
| 9GMR_K | Q9NRC8 | NAD-dependent protein deacetylase sirtuin- | EM | 2.80 | 2024-08-29 | — | 88.00 | 0.88 | — | — | — | 0.11 | ok |
| 8Y1Y_B | Q16611 | BH3 peptide from Bcl-2 homologous antagoni | X-ray | 2.01 | 2024-01-25 | 0.00 | 80.59 | 0.64 | 0.90 | 70.00 | 2.30 | 0.10 | ok |
| 8Y3S_A | P08727 | Keratin, type I cytoskeletal 19 | NMR | — | 2024-01-29 | — | 45.25 | 0.25 | 0.66 | 52.27 | 3.74 | 0.10 | ok |
| 9EBS_C | P0CG48 | Ubiquitin | EM | 3.30 | 2024-11-13 | — | 88.62 | 0.89 | — | — | — | 0.09 | ok |
| 9CSL_A | O95749 | Geranylgeranyl pyrophosphate synthase | X-ray | 2.10 | 2024-07-24 | — | 94.56 | 0.91 | — | — | — | 0.09 | ok |
| 9K27_C | P59768 | Guanine nucleotide-binding protein G(I)/G( | EM | 2.68 | 2024-10-17 | — | 89.56 | 0.91 | — | — | — | 0.08 | ok |
| 9K27_A | P49683 | Prolactin-releasing peptide receptor | EM | 2.68 | 2024-10-17 | — | 80.56 | 0.90 | — | — | — | 0.08 | ok |
| 9K26_G | P59768 | Guanine nucleotide-binding protein G(I)/G( | EM | 3.00 | 2024-10-17 | — | 89.56 | 0.92 | — | — | — | 0.08 | ok |
| 9K26_A | P49683 | Prolactin-releasing peptide receptor | EM | 3.00 | 2024-10-17 | — | 80.56 | 0.91 | — | — | — | 0.07 | ok |
| 9GMK_C | Q6FI13 | Histone H2A type 2-A | EM | 3.50 | 2024-08-29 | — | 91.00 | 0.92 | — | — | — | 0.07 | ok |
| 9BPU_C | K9M1U5 | Interferon lambda-4 | EM | 3.26 | 2024-05-08 | — | 77.44 | 0.92 | — | — | — | 0.06 | ok |
| 9GMR_C | Q6FI13 | Histone H2A type 2-A | EM | 2.80 | 2024-08-29 | — | 91.00 | 0.93 | — | — | — | 0.06 | ok |
| 9BQI_A | Q99571 | P2X purinoceptor 4 | EM | 2.55 | 2024-05-09 | — | 89.25 | 0.94 | — | — | — | 0.06 | ok |
| 9BUM_A | P38435 | Vitamin K-dependent gamma-carboxylase | EM | 3.63 | 2024-05-17 | — | 86.00 | 0.93 | — | — | — | 0.06 | ok |
| 9BPU_A | Q08334 | Interleukin-10 receptor subunit beta | EM | 3.26 | 2024-05-08 | — | 82.12 | 0.93 | — | — | — | 0.06 | ok |
| 9BQH_A | Q99571 | P2X purinoceptor 4 | EM | 2.27 | 2024-05-09 | — | 89.25 | 0.94 | — | — | — | 0.06 | ok |
| 9FQS_A | P00533 | Epidermal growth factor receptor | X-ray | 1.78 | 2024-06-17 | — | 75.94 | 0.93 | — | — | — | 0.05 | ok |
| 8VVY_A | Q13616 | Cullin-1 | EM | 3.49 | 2024-01-31 | — | 88.75 | 0.94 | — | — | — | 0.05 | ok |
| 9IIF_A | Q9NWT6 | Hypoxia-inducible factor 1-alpha inhibitor | X-ray | 2.16 | 2024-06-20 | — | 91.38 | 0.95 | — | — | — | 0.05 | ok |
| 9FSN_A | Q9NWT6 | Hypoxia-inducible factor 1-alpha inhibitor | X-ray | 2.20 | 2024-06-21 | — | 91.38 | 0.95 | — | — | — | 0.04 | ok |
| 9GMR_A | Q71DI3 | Histone H3.2 | EM | 2.80 | 2024-08-29 | — | 86.00 | 0.95 | — | — | — | 0.04 | ok |
| 8K6I_E | P0CG48 | ubiquitin | X-ray | 3.19 | 2023-07-25 | — | 88.62 | 0.95 | — | — | — | 0.04 | ok |
| 9FL8_B | Q92600 | CCR4-NOT transcription complex subunit 9 | X-ray | 2.64 | 2024-06-04 | — | 92.44 | 0.96 | — | — | — | 0.04 | ok |
| 9FQP_A | P00533 | Epidermal growth factor receptor | X-ray | 2.50 | 2024-06-17 | — | 75.94 | 0.95 | — | — | — | 0.04 | ok |
| 9FRD_A | P00533 | Epidermal growth factor receptor | X-ray | 2.06 | 2024-06-18 | — | 75.94 | 0.95 | — | — | — | 0.04 | ok |
| 8ZI9_F | P68032 | Actin, alpha cardiac muscle 1 | EM | 3.08 | 2024-05-13 | — | 95.38 | 0.96 | — | — | — | 0.04 | ok |
| 8ZJ1_A | P68032 | Actin, alpha cardiac muscle 1 | EM | 4.25 | 2024-05-14 | — | 95.38 | 0.96 | — | — | — | 0.04 | ok |
| 8ZB7_A | P68032 | Actin, alpha cardiac muscle 1 | EM | 3.19 | 2024-04-26 | — | 95.38 | 0.96 | — | — | — | 0.04 | ok |
| 8Y3F_C | P04908 | Histone H2A type 1-B/E | EM | 4.54 | 2024-01-29 | — | 90.75 | 0.96 | — | — | — | 0.04 | ok |
| 9DON_A | P06730 | Eukaryotic translation initiation factor 4 | X-ray | 2.09 | 2024-09-19 | — | 90.94 | 0.96 | — | — | — | 0.04 | ok |
| 8Y3E_C | P04908 | Histone H2A type 1-B/E | EM | 5.32 | 2024-01-29 | — | 90.75 | 0.96 | — | — | — | 0.04 | ok |
| 9GMK_A | Q71DI3 | Histone H3.2 | EM | 3.50 | 2024-08-29 | — | 86.00 | 0.96 | — | — | — | 0.04 | ok |
| 9GMK_D | P06899 | Histone H2B type 1-J | EM | 3.50 | 2024-08-29 | — | 85.50 | 0.96 | — | — | — | 0.04 | ok |
| 9C48_A | Q99571 | P2X purinoceptor 4 | EM | 2.40 | 2024-06-03 | — | 89.25 | 0.96 | — | — | — | 0.04 | ok |
| 8VS0_A | P53779 | Mitogen-activated protein kinase 10 | X-ray | 2.46 | 2024-01-23 | — | 79.31 | 0.96 | — | — | — | 0.03 | ok |
| 8Y3D_C | P04908 | Histone H2A type 1-B/E | EM | 5.10 | 2024-01-29 | — | 90.75 | 0.96 | — | — | — | 0.03 | ok |
| 9GMK_B | P62805 | Histone H4 | EM | 3.50 | 2024-08-29 | — | 89.81 | 0.96 | — | — | — | 0.03 | ok |
| 8K6F_E | P0CG48 | Ubiquitin | X-ray | 3.41 | 2023-07-25 | — | 88.62 | 0.96 | — | — | — | 0.03 | ok |
| 9EBS_E | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | EM | 3.30 | 2024-11-13 | — | 59.59 | 0.94 | — | — | — | 0.03 | ok |
| 8VTF_A | P53779 | Mitogen-activated protein kinase 10 | X-ray | 2.40 | 2024-01-26 | — | 79.31 | 0.96 | — | — | — | 0.03 | ok |
| 8Y3C_C | P04908 | Histone H2A type 1-B/E | EM | 5.21 | 2024-01-29 | — | 90.75 | 0.97 | — | — | — | 0.03 | ok |
| 8YCP_A | Q8NER1 | Transient receptor potential cation channe | EM | 2.87 | 2024-02-18 | — | 71.94 | 0.96 | — | — | — | 0.03 | ok |
| 9BPU_B | Q8IU57 | Interferon lambda receptor 1 | EM | 3.26 | 2024-05-08 | — | 64.25 | 0.95 | — | — | — | 0.03 | ok |
| 9GMR_B | P62805 | Histone H4 | EM | 2.80 | 2024-08-29 | — | 89.81 | 0.97 | — | — | — | 0.03 | ok |
| 8Y1Z_A | Q07820 | Induced myeloid leukemia cell differentiat | X-ray | 1.91 | 2024-01-25 | — | 63.62 | 0.96 | — | — | — | 0.03 | ok |
| 8VCG_A | P12931 | Isoform 3 of Proto-oncogene tyrosine-prote | X-ray | 1.61 | 2023-12-14 | — | 83.44 | 0.97 | — | — | — | 0.03 | ok |
| 9BPV_B | Q8IU57 | Interferon lambda receptor 1 | EM | 3.00 | 2024-05-08 | — | 64.25 | 0.96 | — | — | — | 0.03 | ok |
| 9GY0_E | P12004 | Proliferating cell nuclear antigen | EM | 3.42 | 2024-10-01 | — | 94.31 | 0.97 | — | — | — | 0.03 | ok |
| 8K6V_C | P0CG48 | Ubiquitin | X-ray | 2.60 | 2023-07-25 | — | 88.62 | 0.97 | — | — | — | 0.03 | ok |
| 8Z05_B | P61769 | Beta-2-microglobulin | X-ray | 1.96 | 2024-04-09 | — | 94.06 | 0.97 | — | — | — | 0.02 | ok |
| 9IPW_B | Q15369 | Elongin-C | X-ray | 3.00 | 2024-07-11 | — | 89.81 | 0.97 | — | — | — | 0.02 | ok |
| 8VCF_A | P12931 | Isoform 3 of Proto-oncogene tyrosine-prote | X-ray | 1.50 | 2023-12-14 | — | 83.44 | 0.97 | — | — | — | 0.02 | ok |
| 9EOA_A | Q9Y2M0 | Fanconi-associated nuclease 1 | EM | 3.27 | 2024-03-14 | — | 69.88 | 0.97 | — | — | — | 0.02 | ok |
| 9EOA_F | P12004 | Proliferating cell nuclear antigen | EM | 3.27 | 2024-03-14 | — | 94.31 | 0.98 | — | — | — | 0.02 | ok |
| 9EO1_A | Q9Y2M0 | Fanconi-associated nuclease 1 | EM | 3.20 | 2024-03-14 | — | 69.88 | 0.97 | — | — | — | 0.02 | ok |
| 9FL8_A | A5YKK6 | CCR4-NOT transcription complex subunit 1 | X-ray | 2.64 | 2024-06-04 | — | 74.12 | 0.97 | — | — | — | 0.02 | ok |
| 9BPV_A | Q08334 | Interleukin-10 receptor subunit beta | EM | 3.00 | 2024-05-08 | — | 82.12 | 0.97 | — | — | — | 0.02 | ok |
| 9EBS_D | Q8TAF3 | WD repeat-containing protein 48 | EM | 3.30 | 2024-11-13 | — | 88.88 | 0.98 | — | — | — | 0.02 | ok |
| 8K6R_C | P0CG48 | Ubiquitin | X-ray | 2.76 | 2023-07-25 | — | 88.62 | 0.98 | — | — | — | 0.02 | ok |
| 8K4V_B | P61769 | Beta-2-microglobulin | X-ray | 3.10 | 2023-07-20 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 9CBB_A | Q9NRM0 | Soluble cytochrome b562,Solute carrier fam | EM | 4.15 | 2024-06-18 | — | 82.62 | 0.97 | — | — | — | 0.02 | ok |
| 9GY0_A | Q9Y2M0 | Fanconi-associated nuclease 1 | EM | 3.42 | 2024-10-01 | — | 69.88 | 0.97 | — | — | — | 0.02 | ok |
| 8YZW_B | P61769 | Beta-2-microglobulin | X-ray | 2.36 | 2024-04-08 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 8Z07_B | P61769 | Beta-2-microglobulin | X-ray | 2.70 | 2024-04-09 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 9BUR_A | P38435 | Vitamin K-dependent gamma-carboxylase | EM | 2.95 | 2024-05-17 | — | 86.00 | 0.98 | — | — | — | 0.02 | ok |
| 9BUX_A | P38435 | Vitamin K-dependent gamma-carboxylase | EM | 3.06 | 2024-05-17 | — | 86.00 | 0.98 | — | — | — | 0.02 | ok |
| 8Z08_D | P61769 | Beta-2-microglobulin | X-ray | 2.01 | 2024-04-09 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 8YZZ_B | P61769 | Beta-2-microglobulin | X-ray | 1.88 | 2024-04-08 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 8Z05_A | A0A140T955 | HLA class I histocompatibility antigen, A | X-ray | 1.96 | 2024-04-09 | — | 92.25 | 0.98 | — | — | — | 0.02 | ok |
| 9BPV_C | Q8IZI9 | Interferon lambda-3 | EM | 3.00 | 2024-05-08 | — | 84.81 | 0.98 | — | — | — | 0.02 | ok |
| 8Z06_B | P61769 | Beta-2-microglobulin | X-ray | 2.39 | 2024-04-09 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 8YZR_B | P61769 | Beta-2-microglobulin | X-ray | 1.80 | 2024-04-08 | — | 94.06 | 0.98 | — | — | — | 0.02 | ok |
| 9GMR_D | P06899 | Histone H2B type 1-J | EM | 2.80 | 2024-08-29 | — | 85.50 | 0.98 | — | — | — | 0.01 | ok |
| 8K50_B | P61769 | Beta-2-microglobulin | X-ray | 2.80 | 2023-07-20 | — | 94.06 | 0.99 | — | — | — | 0.01 | ok |
| 8K4T_B | P61769 | Beta-2-microglobulin | X-ray | 2.30 | 2023-07-20 | — | 94.06 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3D_B | P62805 | Histone H4 | EM | 5.10 | 2024-01-29 | — | 89.81 | 0.99 | — | — | — | 0.01 | ok |
| 8YQD_A | P02766 | Transthyretin | X-ray | 1.69 | 2024-03-19 | — | 88.00 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3E_B | P62805 | Histone H4 | EM | 5.32 | 2024-01-29 | — | 89.81 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3F_D | P06899 | Histone H2B type 1-J | EM | 4.54 | 2024-01-29 | — | 85.50 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3C_D | P06899 | Histone H2B type 1-J | EM | 5.21 | 2024-01-29 | — | 85.50 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3D_D | P06899 | Histone H2B type 1-J | EM | 5.10 | 2024-01-29 | — | 85.50 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3F_B | P62805 | Histone H4 | EM | 4.54 | 2024-01-29 | — | 89.81 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3D_A | P68431 | Histone H3.1 | EM | 5.10 | 2024-01-29 | — | 86.06 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3F_A | P68431 | Histone H3.1 | EM | 4.54 | 2024-01-29 | — | 86.06 | 0.99 | — | — | — | 0.01 | ok |
| 9FJX_B | Q96SW2 | Protein cereblon | X-ray | 2.00 | 2024-05-31 | — | 86.62 | 0.99 | — | — | — | 0.01 | ok |
| 9IPW_A | Q15370 | Elongin-B | X-ray | 3.00 | 2024-07-11 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 8W2I_A | P17858 | ATP-dependent 6-phosphofructokinase, liver | EM | 3.60 | 2024-02-20 | — | 92.56 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3E_A | P68431 | Histone H3.1 | EM | 5.32 | 2024-01-29 | — | 86.06 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3E_D | P06899 | Histone H2B type 1-J | EM | 5.32 | 2024-01-29 | — | 85.50 | 0.99 | — | — | — | 0.01 | ok |
| 8K4T_A | P04439 | HLA class I histocompatibility antigen, A | X-ray | 2.30 | 2023-07-20 | — | 87.12 | 0.99 | — | — | — | 0.01 | ok |
| 8Y1Y_A | Q07820 | Induced myeloid leukemia cell differentiat | X-ray | 2.01 | 2024-01-25 | — | 63.62 | 0.99 | — | — | — | 0.01 | ok |
| 8Z06_A | A0A143Y4R2 | MHC class I antigen | X-ray | 2.39 | 2024-04-09 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3C_A | P68431 | Histone H3.1 | EM | 5.21 | 2024-01-29 | — | 86.06 | 0.99 | — | — | — | 0.01 | ok |
| 8ROS_AAA | Q9NVS9 | Pyridoxine-5'-phosphate oxidase | X-ray | 1.55 | 2024-01-12 | — | 88.56 | 0.99 | — | — | — | 0.01 | ok |
| 8K4V_A | P04439 | HLA class I histocompatibility antigen, A | X-ray | 3.10 | 2023-07-20 | — | 87.12 | 0.99 | — | — | — | 0.01 | ok |
| 8Y3C_B | P62805 | Histone H4 | EM | 5.21 | 2024-01-29 | — | 89.81 | 0.99 | — | — | — | 0.01 | ok |
| 8K50_A | P04439 | HLA class I histocompatibility antigen, A | X-ray | 2.80 | 2023-07-20 | — | 87.12 | 0.99 | — | — | — | 0.01 | ok |
| 8YZR_A | A0A143Y4R2 | MHC class I antigen | X-ray | 1.80 | 2024-04-08 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 9CAX_A | Q9NRM0 | Soluble cytochrome b562,Solute carrier fam | EM | 3.37 | 2024-06-18 | — | 82.62 | 0.99 | — | — | — | 0.01 | ok |
| 9K26_B | P62873 | Guanine nucleotide-binding protein G(I)/G( | EM | 3.00 | 2024-10-17 | — | 97.06 | 0.99 | — | — | — | 0.01 | ok |
| 8Z07_A | A0A143Y4R2 | MHC class I antigen | X-ray | 2.70 | 2024-04-09 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 9IPW_C | P40337 | von Hippel-Lindau disease tumor suppressor | X-ray | 3.00 | 2024-07-11 | — | 84.44 | 0.99 | — | — | — | 0.01 | ok |
| 8ROU_A | P00918 | Carbonic anhydrase 2 | X-ray | 1.08 | 2024-01-12 | — | 97.38 | 0.99 | — | — | — | 0.01 | ok |
| 8YZW_A | A0A143Y4R2 | MHC class I antigen | X-ray | 2.36 | 2024-04-08 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 8RNS_A | P00918 | Carbonic anhydrase 2 | X-ray | 1.14 | 2024-01-10 | — | 97.38 | 0.99 | — | — | — | 0.01 | ok |
| 8Z08_C | A0A143Y4R2 | MHC class I antigen | X-ray | 2.01 | 2024-04-09 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 8YZZ_A | A0A143Y4R2 | MHC class I antigen | X-ray | 1.88 | 2024-04-08 | — | 92.50 | 0.99 | — | — | — | 0.01 | ok |
| 9K27_B | P62873 | Guanine nucleotide-binding protein G(I)/G( | EM | 2.68 | 2024-10-17 | — | 97.06 | 0.99 | — | — | — | 0.01 | ok |
| 8ROW_A | P00918 | Carbonic anhydrase 2 | X-ray | 1.05 | 2024-01-12 | — | 97.38 | 1.00 | — | — | — | 0.00 | ok |
| 8RRA_A | P17931 | Galectin-3 | X-ray | 1.30 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RR7_A | P17931 | Galectin-3 | X-ray | 1.60 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 9JA8_A | Q9Y233 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic | X-ray | 2.40 | 2024-08-24 | — | 69.38 | 0.99 | — | — | — | 0.00 | ok |
| 8RRF_A | P17931 | Galectin-3 | X-ray | 1.25 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RMU_A | P17931 | Galectin-3 | X-ray | 1.20 | 2024-01-08 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RRE_A | P17931 | Galectin-3 | X-ray | 1.21 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RMT_A | P17931 | Galectin-3 | X-ray | 1.25 | 2024-01-08 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RRG_A | P17931 | Galectin-3 | X-ray | 1.40 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RR8_A | P17931 | Galectin-3 | X-ray | 1.50 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RR9_A | P17931 | Galectin-3 | X-ray | 1.25 | 2024-01-22 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RMV_A | P17931 | Galectin-3 | X-ray | 1.35 | 2024-01-08 | — | 73.81 | 0.99 | — | — | — | 0.00 | ok |
| 8RRC_A | P17931 | Galectin-3 | X-ray | 1.50 | 2024-01-22 | — | 73.81 | 1.00 | — | — | — | 0.00 | ok |
| 8RRB_A | P17931 | Galectin-3 | X-ray | 1.20 | 2024-01-22 | — | 73.81 | 1.00 | — | — | — | 0.00 | ok |
| 9KWM_A | P23141 | Liver carboxylesterase 1 | X-ray | 1.89 | 2024-12-06 | — | 93.31 | 1.00 | — | — | — | 0.00 | ok |
| 9KWL_A | P23141 | Liver carboxylesterase 1 | X-ray | 1.83 | 2024-12-06 | — | 93.31 | 1.00 | — | — | — | 0.00 | ok |
Click a column header to sort. FRAUD = confidence-weighted error; a structure is flagged confidently wrong when mean pLDDT > 70 yet TM-score < 0.5.